Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China-Reference-Cited by-同舟云学术

Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China

Published:2007-07 Issue:4 Volume:13 Page:351-356
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

SHI J.,ZHAO Y.,WU J.,SUN J.,WANG L.,YANG R.

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2007.01472.x/fullpdf

Reference24 articles.

1. The tragic history of AIDS in the hemophilia population, 1982-1984

2. Retrospective analysis of 1312 patients with haemophilia and related disorders in a single Chinese institute

3. Hepatitis A Virus Infection among the Hemophilia Population at the Bonn Hemophilia Center

4. A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A Therapies;Journal of Pharmaceutical Sciences;2023-09

Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies

;Journal of Blood Medicine;2020-11

Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial

;Therapeutics and Clinical Risk Management;2020-06

4. Efficacy and safety of prophylaxis with BAY 81‐8973 in Chinese patients with severe haemophilia A enrolled in the LEOPOLD II trial;Haemophilia;2019-04-17

5. Long-term efficacy and safety of prophylaxis with recombinant factor VIII in Chinese pediatric patients with hemophilia A: a multi-center, retrospective, non-interventional, phase IV (ReCARE) study;Current Medical Research and Opinion;2017-04-25